• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,391.25
    -41.55 (--0.07%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,047.00(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,058.45(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Emcure Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 16966.0
  • ISIN : INE168P01015
1,009.10 -27 (-2.57%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    1,006.00

  • Today’s High

    1,051.50

  • Open

    1,047.90

  • Perv Close

    1,035.70

  • 52W Low

    889.00

  • 52W High

    1,580.00

Key Indicators

  • P/E(TTM)

    89.46

  • Mar.Cap (₹Cr.)

    19,120.76

  • Div & Yield %

    0.19

  • Book Value(₹)

    149.28

  • Debt-Equity Ratio

    -2.57

  • AGM Date

    29-Apr-2025

  • EPS

    11.30

  • P/E Ratio

    89.46

Financials Ratios

  • Debt-Equity Ratio

    0.86

  • Mar.Cap (₹Cr.)

    19,120.76

  • RONW (%)

    19.35

  • ROCE (%)

    18.23

Score Board

  • Equity (₹ in Cr.)

    189.48

  • BV (₹)

    149.30

  • Sales( ₹ in Cr.)

    3,497.66

  • NP (in Cr.)

    162.48

  • NP Var(%)

    -1.0

  • Div%

    20.0

  • CPS (₹)

    19.40

  • EPS (₹)

    8.60

  • Traded Value (₹ in Lakhs)

    19,154.87

  • 52 Week High

    1,580.00

  • 52 Week Low

    889.00

  • Price BSE

    1011.0

  • Price NSE

    1,009.00

  • Market Capital( in Cr.)

    19,154.87

  • P/C Ratio

    52.20

  • P/E Ratio

    117.90

  • Price Vs.BV

    8.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 3,497.66 3,107.09 3,387.24 3,107.41 2,375.71 2,453.70
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,497.66 3,107.09 3,387.24 3,107.41 2,375.71 2,453.70
Other Income 138.26 125.35 132.68 96.52 137.62 90.88
Stock Adjustments 101.70 -14.45 36.10 107.96 -59.70 -14.71
Total Income 3,737.62 3,217.99 3,556.02 3,311.89 2,453.63 2,529.87
EXPENDITURE :            
Raw Materials 1,464.67 1,199.25 1,354.99 1,345.85 751.46 730.09
Power and Fuel Cost 88.73 80.41 72.46 73.51 67.29 61.44
Employee Cost 706.41 649.18 603.95 543.92 545.35 516.14
Other Manufacturing Expenses 209.89 192.67 219.39 198.00 127.43 186.81
Selling and Administration Expenses 532.87 443.20 263.11 226.17 342.04 279.22
Miscellaneous Expenses 164.22 95.59 114.78 94.06 103.18 129.84
Employee Benefit Expenses 706.41 649.18 603.95 543.92 545.35 516.14
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 3,166.78 2,660.30 2,628.67 2,481.51 1,936.75 1,903.54
Operating Profit 570.83 557.69 927.36 830.39 516.88 626.33
Interest 166.09 166.83 145.14 118.28 137.22 126.65
Gross Profit 404.74 390.86 782.22 712.11 379.66 499.68
Depreciation 204.83 178.52 165.79 154.21 154.97 129.84
Profit Before Tax 199.91 212.34 616.43 557.90 224.69 369.84
Current Tax 38.58 53.10 168.72 141.65 72.81 91.35
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.50 -0.83 0.89 -4.23 -23.34 -5.17
Reported Net Profit 160.83 160.06 446.81 420.48 175.21 283.65
Extraordinary Items -1.64 -4.80 0.10 -2.90 -32.65 -26.32
Adjusted Net Profit 162.47 164.86 446.71 423.38 207.86 309.97
Adjustment below Net Profit -5.34 4.06 -0.79 0.11 -2.03 0.11
P & L Balance brought forward 1,593.84 1,465.89 1,877.11 1,474.61 1,349.71 989.73
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 54.26 36.17 857.24 18.09 48.27 -76.22
P & L Balance carried down 1,695.08 1,593.84 1,465.89 1,877.11 1,474.61 1,349.71
Dividend 0.00 0.00 36.17 0.00 0.00 45.21
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 20.00 20.00 30.00 10.00 25.00 25.00
Dividend Per Share(Rs) 2.00 2.00 3.00 1.00 2.50 2.50
Earnings Per Share-Unit Curr 8.88 8.85 24.71 23.25 9.69 15.68
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 106.82 101.84 94.69 127.27 105.86 98.29
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    77.92%

  • Public Share Holding

    22.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 433,932 433,932.00 433,932 433,932
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 433,932 0.23 433,932 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 118,187,350 62.37 118,187,350 16
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 29,028,000 15.32 29,028,000 2
Others 0 0.00 0 0
Sub Total 147,215,350 77.69 147,215,350 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,811,652 3.07 5,811,652 48
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 366,368 0.19 366,368 3
Mutual Funds / UTI 5,171,429 2.73 5,171,429 21
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 979,195 0.52 979,195 16
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 12,328,644 6.51 12,328,644 88
2] Non Institution
Bodies Corporate 770,888 0.41 770,888 266
Clearing Members 0 0.00 0 0
Directors of their Relatives 343,930 0.18 343,930 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,167,044 0.62 1,167,044 943
Foreign Non Institution Other 16,439,459 8.68 16,439,459 1
Hindu Undivided Families 171,004 0.09 171,004 3,389
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,547,244 2.93 5,547,244 30
Individuals holding nominal share capital up to Rs. 1 lakh 4,893,825 2.58 4,893,821 134,898
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,568 0.00 1,568 3
Others 30,750 0.02 30,750 1
Sub Total 29,505,421 15.57 29,505,417 139,563
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 189,483,347 100.00 189,483,343 139,671

Company Background

Emcure Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Emcure Pharmaceuticals Ltd
  • BSE Code : 16966.0
  • ISIN : INE168P01015

  • Incorporation Year

    1981

  • Registered Office

    Plot # P-1 & P-2 IT BT Park
    Phase II MIDC Hinjawadi, Pune,
    Maharashtra-411057

  • Telephone

    +91 20 3507 0033/+91 20 3507 0000

  • FAX

  • Chairman

    Berjis M Desai

  • Managing Director

    SATISH RAMANLAL MEHTA

  • Company Secretary

    CHETAN RAJENDRA SHARMA

  • Auditor

    B S R & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Emcure Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Emcure Pharma 1,010.90 3,635.91 3,497.66 92.74 10.08
Abbott India 30,094.35 6,097.18 5,848.91 47.92 44.71
Astrazeneca Phar 8,795.90 1,330.33 1,295.53 226.76 33.26
P & G Health Ltd 5,121.00 1,166.89 1,151.26 35.93 39.76
Glaxosmi. Pharma 2,904.45 3,530.73 3,407.25 57.75 44.44
Cipla 1,541.00 17,645.00 16,574.34 26.42 20.10
Amrutanjan Healt 679.10 437.58 421.23 39.81 20.84
Guj. Themis Bio. 285.15 174.19 169.82 59.04 44.82
Fermenta Biotec. 272.25 315.24 307.09 25.81 4.10
Bliss GVS Pharma 122.65 638.96 605.46 28.07 11.19
Ambalal Sarabhai 37.10 11.70 3.81 15.85 1.92